Stocks
Revelation Biosciences, Inc.REVB
NASDAQHealthcareBiotechnology$1.26+2.06%
Price as of · delayed, not real-time
Focused on developing immunotherapies and diagnostics for infectious diseases, this biotech firm aims to address unmet medical needs through innovative therapeutic approaches. Investors monitor its progress due to its pipeline potential and partnerships in the healthcare sector.
Market Cap: $1.9M52W Range: $1.19 – $44.77
Congressional Interest in Revelation Biosciences, Inc. (REVB)
1 member of Congress has disclosed 13 trades in Revelation Biosciences, Inc. (REVB), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 13 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
13
Unique Politicians
1
Buys
0
Sells
13
Who in Congress Is Trading REVB?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2019-07-31 | Patrick J Toomey | sell | $15K – $50K |
| 2018-07-27 | Patrick J Toomey | sell | $15K – $50K |
| 2018-06-25 | Patrick J Toomey | sell | $1K – $15K |
| 2018-06-06 | Patrick J Toomey | sell | $15K – $50K |
| 2018-05-16 | Patrick J Toomey | sell | $1K – $15K |
| 2018-04-30 | Patrick J Toomey | sell | $1K – $15K |
| 2018-03-22 | Patrick J Toomey | sell | $1K – $15K |
| 2018-02-08 | Patrick J Toomey | sell | $1K – $15K |
| 2018-01-30 | Patrick J Toomey | sell | $1K – $15K |
| 2017-12-07 | Patrick J Toomey | sell | $1K – $15K |
| 2017-11-30 | Patrick J Toomey | sell | $1K – $15K |
| 2017-11-17 | Patrick J Toomey | sell | $1K – $15K |
| 2017-11-15 | Patrick J Toomey | sell | $1K – $15K |